Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-25 5:30 pm Sale |
2022-12-30 | 13G | TPCO Holding Corp. GRAMF |
Cowen Financial Products LLC | 0 0.000% |
-5,592,948 (Position Closed) |
Filing History |
| 2023-01-25 3:57 pm Unchanged |
2022-12-30 | 13G | VIREO HEALTH INTL INC VREOF |
Cowen Financial Products LLC | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2023-01-25 3:53 pm Unchanged |
2022-12-30 | 13G | Vext Science, Inc. VEXTF |
Cowen Financial Products LLC | 4,856,256 6.880% |
0 (Unchanged) |
Filing History |
| 2023-01-25 3:51 pm Purchase |
2022-12-30 | 13G | Trulieve Cannabis Corp. TCNNF |
Cowen Financial Products LLC | 11,148,292 6.980% |
4,101,929 (+58.21%) |
Filing History |
| 2023-01-25 3:47 pm Sale |
2022-12-30 | 13G | TERRASCEND CORP TSNDF |
Cowen Financial Products LLC | 9,616,988 3.800% |
-2,014,042 (-17.32%) |
Filing History |
| 2023-01-25 3:45 pm Sale |
2022-12-30 | 13G | Stoke Therapeutics, Inc. STOK |
Cowen Financial Products LLC | 1,248,077 1.890% |
-623,452 (-33.31%) |
Filing History |
| 2023-01-24 2:52 pm Unchanged |
2022-12-30 | 13G | SOL Global Investments Corp. SOLCF |
Cowen Financial Products LLC | 3,434,625 6.310% |
0 (Unchanged) |
Filing History |
| 2023-01-24 2:49 pm Unchanged |
2022-12-30 | 13G | Project Energy Reimagined Acquisition Corp. PEGRU |
Cowen Financial Products LLC | 1,500,000 5.680% |
0 (Unchanged) |
Filing History |
| 2023-01-24 2:44 pm Sale |
2022-12-30 | 13G | PMV Pharmaceuticals, Inc. PMVP |
Cowen Financial Products LLC | 1,500,326 3.280% |
-799,674 (-34.77%) |
Filing History |
| 2023-01-24 2:40 pm Sale |
2022-12-30 | 13G | Medicus Sciences Acquisition Corp. MSAC |
Cowen Financial Products LLC | 0 0.000% |
-500,000 (Position Closed) |
Filing History |
| 2023-01-23 5:14 pm Unchanged |
2022-12-30 | 13G | Goodness Growth Holdings, Inc. GDNSF |
Cowen Financial Products LLC | 4,140,230 3.850% |
0 (Unchanged) |
Filing History |
| 2023-01-23 5:13 pm Sale |
2022-12-30 | 13G | Exagen Inc. XGN |
Cowen Financial Products LLC | 966,022 5.920% |
-418,609 (-30.23%) |
Filing History |
| 2023-01-23 3:52 pm Unchanged |
2022-12-30 | 13G | Lowell Farms Inc. LOWLF |
Cowen Financial Products LLC | 456,450 4.530% |
0 (Unchanged) |
Filing History |
| 2023-01-23 3:49 pm Unchanged |
2022-12-30 | 13G | LL FLOORING HOLDINGS, INC. LLFLQ |
Cowen Financial Products LLC | 1,622,000 5.530% |
0 (Unchanged) |
Filing History |
| 2023-01-23 3:48 pm Purchase |
2022-12-30 | 13G | Jounce Therapeutics, Inc. JNCE |
Cowen Financial Products LLC | 3,647,430 7.050% |
567,078 (+18.41%) |
Filing History |
| 2023-01-23 3:46 pm Purchase |
2022-12-30 | 13G | Green Thumb Industries Inc. GTBIF |
Cowen Financial Products LLC | 14,938,509 7.200% |
3,894,194 (+35.26%) |
Filing History |
| 2023-01-23 3:41 pm Sale |
2022-12-30 | 13G | Fulcrum Therapeutics, Inc. FULC |
Cowen Financial Products LLC | 1,367,759 2.615% |
-729,131 (-34.77%) |
Filing History |
| 2023-01-23 3:33 pm Purchase |
2022-12-30 | 13G | Cresco Labs Inc. CRLBF |
Cowen Financial Products LLC | 19,170,307 6.820% |
5,023,971 (+35.51%) |
Filing |
| 2023-01-23 3:31 pm Unchanged |
2022-12-30 | 13G | C21 Investments Inc. CXXIF |
Cowen Financial Products LLC | 7,906,852 6.562% |
0 (Unchanged) |
Filing History |
| 2023-01-23 3:28 pm Sale |
2022-12-30 | 13G | BREEZE HLDGS ACQUISITION CORP BRZHR |
Cowen Financial Products LLC | 250,000 5.175% |
-188,959 (-43.05%) |
Filing History |